医療産業における人工知能(AI)の欧州市場予測

◆英語タイトル:EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FORECAST 2017-2025
◆商品コード:INKW711033
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年10月
◆ページ数:76
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:欧州
◆産業分野:IT
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥140,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥168,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥224,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSEurope artificial intelligence in healthcare market generated a revenue of $350 million in 2016. The market is predicted to rise at a CAGR of 39.33% over the forecast period of 2017-2025 and is estimated to generate $6.95 billion by its end.
MARKET INSIGHTS
The market is segmented according to the offering, application, technology, and end-users. In terms of technology, the natural language processing is expected to lead the segment. By application, the market for the patient data and risk analysis is expected to lead the AI in healthcare market over the forecast period. The growing use of AI for innovative surgeries and a balanced healthcare worker to patient ratio due to the integration of AI with existing systems is presenting the market with plenty of growth opportunities.
COMPETITIVE INSIGHTS
Some of the distinguished companies in the market are Stryker Corporation, Deep Genomics Inc, Nvidia Corporation, Google Inc, General Vision Inc, Ge Healthcare, Oncore Medical Inc, Welltok Inc, International Business Machines (IBM), Deep Genomics Inc and Microsoft Corporation.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. LARGE SCALE INVESTMENT IN THE ARTIFICIAL INTELLIGENCE MARKET
3.2.2. DEEP LEARNING SHOWS A LARGE DEMAND IN THE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
4. MARKET DYNAMICS
4.1. ETYMOLOGY OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
4.2. MARKET DEFINITION AND SCOPE
4.3. INDUSTRY COMPONENTS
4.3.1. ARTIFICIAL INTELLIGENCE ANALYSIS
4.3.2. DATA WAREHOUSE
4.3.3. SOFTWARE DEVELOPMENT
4.4. LEGAL, POLICY AND REGULATORY ISSUES
4.5. MARKET DRIVERS
4.5.1. RISE IN BIG DATA IN HEALTHCARE INDUSTRY
4.5.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
4.5.3. INCREASING ADOPTION OF ARTIFICIAL INTELLIGENCE (AI) IN GENETICS
4.5.4. AI CREATING A REAL-TIME MONITORING SYSTEM
4.5.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
4.6. MARKET RESTRAINTS
4.6.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
4.6.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
4.7. MARKET OPPORTUNITIES
4.7.1. HEALTHCARE WORKER TO PATIENT RATIO BEING BALANCED WITH AI
4.7.2. USE OF AI IN INNOVATIVE SURGERIES
4.7.3. INTEGRATION WITH EXISTING SYSTEMS
4.8. MARKET CHALLENGES
4.8.1. LACK OF USABLE DATA IN HEALTHCARE
4.8.2. CHALLENGE TO MAINTAIN DATA SECURITY
5. MARKET BY OFFERING
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES
6. MARKET BY TECHNOLOGY
6.1. CONTEXT AWARE PROCESSING
6.2. DEEP LEARNING
6.3. NATURAL LANGUAGE PROCESSING
6.4. QUERYING METHOD
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. INPATIENT CARE & HOSPITAL MANAGEMENT
7.3. LIFESTYLE MANAGEMENT & MONITORING
7.4. MEDICAL IMAGING & DIAGNOSTICS
7.5. PATIENT DATA & RISK ANALYSIS
7.6. PRECISION MEDICINE
7.7. RESEARCH
7.8. VIRTUAL ASSISTANT
7.9. WEARABLES
8. MARKET BY END USERS
8.1. ACOS & MCOS
8.2. PATIENTS
8.3. PAYERS
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.5. PROVIDERS
9. KEY ANALYTICS
9.1. PORTER”S FIVE FORCE ANALYSIS
9.1.1. THREAT OF NEW ENTRANTS
9.1.2. THREAT OF SUBSTITUTE
9.1.3. BARGAINING POWER OF SUPPLIERS
9.1.4. BARGAINING POWER OF BUYERS
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. OPPORTUNITY MATRIX
9.3. KEY BUYING CRITERIA
9.3.1. APPLICATION
9.3.2. TECHNOLOGY
9.3.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
9.4. INVESTMENT ANALYSIS
9.4.1. FASTEST GROWING REVENUE SEGMENT-WISE OPPORTUNITIES
10. GEOGRAPHICAL ANALYSIS
10.1. UNITED KINGDOM
10.2. FRANCE
10.3. GERMANY
10.4. SPAIN
10.5. REST OF EUROPE
11. COMPETITIVE LANDSCAPE
11.1. MARKET SHARE ANALYSIS
11.2. TOP 5 COMPANIES
11.2.1. GOOGLE INC
11.2.2. INTERNATIONAL BUSINESS MACHINES (IBM) CORPORATION
11.2.3. INTEL CORPORATION
11.2.4. MICROSOFT CORPORATION
11.2.5. GE HEALTHCARE
11.3. KEY STRATEGIES
11.3.1. PRODUCT LAUNCH
11.3.2. PARTNERSHIP & COLLABORATION
11.3.3. MERGER & ACQUISITION
11.3.4. INVESTMENTS
11.3.5. EXPANSIONS
11.4. COMPANY PROFILES
11.4.1. DEEP GENOMICS INC.
11.4.1.1. OVERVIEW
11.4.1.2. PRODUCT PORTFOLIO
11.4.1.3. STRATEGIC INITIATIVES
11.4.1.4. SCOT ANALYSIS
11.4.2. ENLITIC INC.
11.4.2.1. OVERVIEW
11.4.2.2. PRODUCT PORTFOLIO
11.4.2.3. STRATEGIC INITIATIVES
11.4.2.4. SCOT ANALYSIS
11.4.3. GE HEALTHCARE
11.4.3.1. OVERVIEW
11.4.3.2. PRODUCT PORTFOLIO
11.4.3.3. STRATEGIC INITIATIVES
11.4.3.4. SCOT ANALYSIS
11.4.4. GENERAL VISION INC
11.4.4.1. OVERVIEW
11.4.4.2. PRODUCT PORTFOLIO
11.4.4.3. STRATEGIC INITIATIVES
11.4.4.4. SCOT ANALYSIS
11.4.5. GOOGLE INC
11.4.5.1. OVERVIEW
11.4.5.2. PRODUCT PORTFOLIO
11.4.5.3. STRATEGIC INITIATIVES
11.4.5.4. SCOT ANALYSIS
11.4.6. INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM)
11.4.6.1. OVERVIEW
11.4.6.2. PRODUCT PORTFOLIO
11.4.6.3. STRATEGIC INITIATIVES
11.4.6.4. SCOT ANALYSIS
11.4.7. ICARBONX
11.4.7.1. OVERVIEW
11.4.7.2. PRODUCT PORTFOLIO
11.4.7.3. STRATEGIC INITIATIVES
11.4.7.4. SCOT ANALYSIS
11.4.8. INTEL CORPORATION
11.4.8.1. OVERVIEW
11.4.8.2. PRODUCT PORTFOLIO
11.4.8.3. STRATEGIC INITIATIVES
11.4.8.4. SCOT ANALYSIS
11.4.9. MICROSOFT CORPORATION
11.4.9.1. OVERVIEW
11.4.9.2. PRODUCT PORTFOLIO
11.4.9.3. STRATEGIC INITIATIVES
11.4.9.4. SCOT ANALYSIS
11.4.10. NEXT IT CORPORATION
11.4.10.1. OVERVIEW
11.4.10.2. PRODUCT PORTFOLIO
11.4.10.3. STRATEGIC INITIATIVES
11.4.10.4. SCOT ANALYSIS
11.4.11. NVIDIA CORPORATION
11.4.11.1. OVERVIEW
11.4.11.2. PRODUCT PORTFOLIO
11.4.11.3. STRATEGIC INITIATIVES
11.4.11.4. SCOT ANALYSIS
11.4.12. ONCORE MEDICAL INC.
11.4.12.1. OVERVIEW
11.4.12.2. PRODUCT PORTFOLIO
11.4.12.3. STRATEGIC INITIATIVES
11.4.12.4. SCOT ANALYSIS
11.4.13. RECURSION PHARMACEUTICALS INC.
11.4.13.1. OVERVIEW
11.4.13.2. PRODUCT PORTFOLIO
11.4.13.3. STRATEGIC INITIATIVES
11.4.13.4. SCOT ANALYSIS
11.4.14. STRYKER CORPORATION
11.4.14.1. OVERVIEW
11.4.14.2. PRODUCT PORTFOLIO
11.4.14.3. STRATEGIC INITIATIVES
11.4.14.4. SCOT ANALYSIS
11.4.15. WELLTOK INC
11.4.15.1. OVERVIEW
11.4.15.2. PRODUCT PORTFOLIO
11.4.15.3. STRATEGIC INITIATIVES
11.4.15.4. SCOT ANALYSIS

TABLE LIST
TABLE 1: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK OF AI IN HEALTHCARE MARKET
TABLE 3: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2017-2025 (IN $ MILLION)
TABLE 4: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2017-2025 (IN $ MILLION)
TABLE 5: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2017-2025 (IN $ MILLION)
TABLE 6: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2017-2025 (IN $ MILLION)
TABLE 7: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 8: LIST OF PRODUCT LAUNCHES IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 9: LIST OF PARTNERSHIP & COLLABORATION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 10: LIST OF MERGER & ACQUISITION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 11: LIST OF INVESTMENTS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 12: LIST OF EXPANSIONS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET

FIGURE LIST
FIGURE 1: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ MILLION)
FIGURE 2: GROWTH OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INCREASING INTERNET USERS IN EUROPE (% OF POPULATION)
FIGURE 5: HEALTHCARE IOT DEVICES INSTALLATIONS
FIGURE 6: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2016 & 2025 (IN $ MILLION)
FIGURE 7: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY HARDWARE, 2017-2025 (IN $ MILLION)
FIGURE 8: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SOFTWARE, 2017-2025 (IN $ MILLION)
FIGURE 9: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SERVICES, 2017-2025 (IN $ MILLION)
FIGURE 10: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2016 & 2025 (IN $ MILLION)
FIGURE 11: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY CONTEXT AWARE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 12: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DEEP LEARNING, 2017-2025 (IN $ MILLION)
FIGURE 13: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY NATURAL LANGUAGE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 14: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY QUERYING METHOD, 2017-2025 (IN $ MILLION)
FIGURE 15: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2016 & 2025 (IN $ MILLION)
FIGURE 16: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DRUG DISCOVERY, 2017-2025 (IN $ MILLION)
FIGURE 17: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY INPATIENT CARE & HOSPITAL MANAGEMENT, 2017-2025 (IN $ MILLION)
FIGURE 18: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY LIFESTYLE MANAGEMENT & MONITORING, 2017-2025 (IN $ MILLION)
FIGURE 19: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY MEDICAL IMAGING & DIAGNOSTICS, 2017-2025 (IN $ MILLION)
FIGURE 20: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENT DATA & RISK ANALYSIS, 2017-2025 (IN $ MILLION)
FIGURE 21: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PRECISION MEDICINE, 2017-2025 (IN $ MILLION)
FIGURE 22: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY RESEARCH, 2017-2025 (IN $ MILLION)
FIGURE 23: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY VIRTUAL ASSISTANT, 2017-2025 (IN $ MILLION)
FIGURE 24: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY WEARABLES, 2017-2025 (IN $ MILLION)
FIGURE 25: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ FIGURE)
FIGURE 26: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ACOS & MCOS, 2017-2025 (IN $ MILLION)
FIGURE 27: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENTS, 2017-2025 (IN $ MILLION)
FIGURE 28: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PAYERS, 2017-2025 (IN $ MILLION)
FIGURE 29: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2025 (IN $ MILLION)
FIGURE 30: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PROVIDERS, 2017-2025 (IN $ MILLION)
FIGURE 31: PORTER’S FIVE FORCE MODEL OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
FIGURE 32: KEY BUYING IMPACT ANALYSIS
FIGURE 33: INVESTMENT ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN 2016, BY FASTEST GROWING REVENUE SEGMENTS
FIGURE 34: EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2016 & 2025 (IN %)
FIGURE 35: UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 36: FRANCE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 37: GERMANY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 38: SPAIN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 39: REST OF EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 40: MARKET SHARE ANALYSIS OF TOP PLAYERS IN 2016 (%)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療産業における人工知能(AI)の欧州市場予測(EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FORECAST 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆